Details
Stereochemistry | ACHIRAL |
Molecular Formula | C2H8N2 |
Molecular Weight | 60.0984 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C(CN)N
InChI
InChIKey=PIICEJLVQHRZGT-UHFFFAOYSA-N
InChI=1S/C2H8N2/c3-1-2-4/h1-4H2
Ethylenediamine is a strongly basic amine useful as a building block in chemical synthesis. It is used as a solvent to dissolve proteins such as albumins, casein and in medicine to stabilize aminophylline when used in injections. Ethylenediamine is used in manufacture of chelating agents (EDTA), epoxy curing agents, dimethylolethylene-urea resins, emulsifying agents, textile lubricants, antifreeze inhibitor. It is also involved in the manufacture of many industrial chemicals and forms derivatives with carboxylic acids, nitriles, alcohols, alkylating agents, carbon disulfide, aldehydes and ketones. It is a basic building block to prepare heterocyclic compound such as imidazolidines.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Kinetics and mechanisms of EDTA photocatalytic degradation with TiO2. | 2001 |
|
Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits. | 2001 Apr |
|
Salts of 3,5-dinitrobenzoic acid with organic diamines: hydrogen-bonded supramolecular structures in one, two and three dimensions. | 2001 Apr |
|
Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. | 2001 Aug |
|
Synthesis and structure of [K(+)-(2,2)diaza-[18]-crown-6][K3Ge9]-2ethylenediamine: stabilization of the two-dimensional layer (2)(infinity)[K3Ge9(1-)]. | 2001 Aug 27 |
|
Enzymatic properties of sialic acid binding lectin from Rana catesbeiana modified with a water-soluble carbodiimide in the presence of various nucleophiles. | 2001 Dec |
|
Cyclodehydration reactions of methyl 9,10-; 10,12-; and 9,1 2-dioxostearates with 1,2-diaminoethane under ultrasonic irradiation. | 2001 Feb |
|
NMR paramagnetic relaxation enhancement: test of the controlling influence of zfs rhombicity for S = 1. | 2001 Feb |
|
Ancillary ligand effect on the properties of "Mg(thd)2" and crystal structures of [Mg(thd)2(ethylenediamine)]2, [Mg(thd)2(tmeda)], and [Mg(thd)2(trien)]. | 2001 Feb 12 |
|
Inhibition of lignin peroxidase-mediated oxidation activity by ethylenediamine tetraacetic acid and N-N-N'-N'-tetramethylenediamine. | 2001 Jan |
|
Phagocytic response of bovine polymorphonuclear leukocytes to different incubation conditions and following exposure to some effectors of phagocytosis and different anticoagulants in vitro. | 2001 Jan |
|
Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterization and cell assay. | 2001 Jan 1 |
|
Di-tert-butyl phosphate complexes of cobalt(II) and zinc(II) as precursors for ceramic M(PO3)2 and M2P2O7 materials: synthesis, spectral characterization, structural studies, and role of auxiliary ligands. | 2001 Jan 29 |
|
Potential energy surface crossings and the mechanistic spectrum for intramolecular electron transfer in organic radical cations. | 2001 Jan 31 |
|
Behaviour of 2-substituted 1,3-indandiones towards aldimines. | 2001 Jan-Feb |
|
Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. | 2001 Jan-Feb |
|
Preparation of a ribonucleic acid-(polyamidoamine)-(zirconia-urea-formaldehyde resin) high-performance liquid affinity chromatographic stationary phase. | 2001 Jul |
|
Tetranuclear mixed-metal M(II)2Cu(II)2 complexes derived from a phenol-based macrocyclic ligand having two N(amine)2O2 and two N(imine)2O2 metal-binding sites. | 2001 Jul 16 |
|
catena-Poly[dibromozinc(II)-mu-ethylenediamine-N:N']: resolution of structural anomalies resulting from the interpretation of vibrational spectra. | 2001 Jun |
|
Biodegradability of ethylenediamine-based complexing agents. | 2001 Jun |
|
Development of an ELISA to measure soluble CD163 in biological fluids. | 2001 Jun 1 |
|
Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patients. | 2001 Mar |
|
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients. | 2001 Mar |
|
Effect of collagenase inhibitors on corneal haze after PRK. | 2001 Mar |
|
Rb(4)Hg(5)(Te(2))(2)(Te(3))(2)Te(3), [Zn(en)3](4)In(16)(Te2)4(Te3)Te22, and K2Cu2(Te2)(Te3): novel metal polytellurides with unusual metal-tellurium coordination. | 2001 Mar 12 |
|
Structures of a tetradentate ferrocenyl ligand and its oxorhenium(V) complex in solution and in the solid state. | 2001 Mar 12 |
|
Chemoenzymatic synthesis of sucrose-containing aromatic polymers. | 2001 Mar 5 |
|
[Effect of alpha-lipoic acid preparations on bilirubin and transferrin levels and ferritin iron and transferrin iron content]. | 2001 Mar-Apr |
|
Sulfite oxidation by iron-grown cells of Thiobacillus ferrooxidans at pH 3 possibly involves free radicals, iron, and cytochrome oxidase. | 2001 May |
|
Improving biomaterial properties of collagen films by chemical modification. | 2001 May 5 |
|
[[Cu(en)(2)](2)Re(4)Te(4)(CN)(12)].5H(2)O and [[Cu(en)(2)](2)Re(6)Te(8)(CN)(6)].5H(2)O: bonding of a transition-metal complex to a rhenium chalcocyanide cluster. | 2001 Nov 19 |
|
Gold-gold interactions as crystal engineering design elements in heterobimetallic coordination polymers. | 2001 Nov 5 |
|
The effect of pH and concentration upon aggregation transitions in aqueous solutions of poloxamine T701. | 2001 Oct 23 |
|
Syntheses, vibrational spectra, and theoretical studies of the adamantanoid Sn(4)Ch(10)(4-) (Ch = Se, Te) anions: X-ray crystal structures of [18-crown-6-K](4)[Sn4Se10]*5en and [18-crown-6-K](4)[Sn4Te10]*3en*2THF. | 2001 Sep 10 |
|
c-erbB-2 is not a major factor in the development of colorectal cancer. | 2002 Feb 12 |
|
Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptide. | 2002 Jan |
|
Galactosylated alginate as a scaffold for hepatocytes entrapment. | 2002 Jan |
|
Syntheses, crystal structures, and density functional theory calculations of the closo-[1-M(CO)(3)(eta(4)-E(9))](4-) (E = Sn, Pb; M = Mo, W) cluster anions and solution NMR spectroscopic characterization of [1-M(CO)(3)(eta(4)-Sn(9))](4-) (M = Cr, Mo, W). | 2002 Jan 14 |
|
Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum. | 2002 Jan 2 |
|
Development of preparation methods for and insights obtained from atomic force microscopy of fluid spaces in cortical bone. | 2002 Jan-Feb |
|
Three different bonding modes of cyano groups in the coordination polymer [Cu(en)2(H(2)O)][Cu(en)(2)Ni(2)Cu(2)(CN)(10)] x 2H(2)O (en is 1,2-diaminoethane). | 2002 Mar |
|
Designed self-assembly of molecular necklaces. | 2002 Mar 13 |
|
Role of magnesium in nucleotide exchange on the small G protein rac investigated using novel fluorescent Guanine nucleotide analogues. | 2002 Mar 19 |
|
[Ph(2)Bi-(Ge(9))-BiPh(2)](2-): a deltahedral Zintl ion functionalized by exo-bonded ligands. | 2002 Mar 20 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
||
|
EPA PESTICIDE CODE |
4205
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
||
|
CFR |
21 CFR 173.320
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4158
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | RxNorm | ||
|
7141
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
N0000171131
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
M5119
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | Merck Index | ||
|
DB14189
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
CHEMBL816
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
CONCEPT | Industrial Aid | ||
|
3301
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
60V9STC53F
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
203-468-6
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
SUB13760MIG
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
107-15-3
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
ETHYLENEDIAMINE
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
N0000184306
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
107-15-3
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
C80898
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
535
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | |||
|
N0000175629
Created by
admin on Fri Jun 25 20:56:48 UTC 2021 , Edited by admin on Fri Jun 25 20:56:48 UTC 2021
|
PRIMARY | Increased Histamine Release [PE] |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)